Search Results for keywords:"C.W. Bill Young Cell Transplantation Program"

Found 3 results
Skip to main content

Search Results: keywords:"C.W. Bill Young Cell Transplantation Program"

  • Type:Notice
    Citation:90 FR 13753
    Reading Time:about a minute or two

    The Department of Health and Human Services has renewed the charter for the Advisory Council on Blood Stem Cell Transplantation (ACBSCT) as announced by the Health Resources and Services Administration (HRSA). This renewal allows the council to continue its operations until February 19, 2027, where it will advise on matters related to blood stem cell transplantation, including the C.W. Bill Young Cell Transplantation Program and National Cord Blood Inventory. ACBSCT provides expert recommendations on stem cell science and potential therapies. The renewal was effective as of February 19, 2025, and details can be accessed online through the council's website or the FACA database.

    Simple Explanation

    The government decided to keep a special group of helpers until 2027, called the Advisory Council on Blood Stem Cell Transplantation, that gives advice about how to use blood stem cells to help people get better. This group helps with important projects, like creating a big collection of special blood cells for sick people who might need them.

  • Type:Notice
    Citation:89 FR 104550
    Reading Time:about 2 minutes

    The Advisory Council on Blood Stem Cell Transplantation will hold a public meeting on January 23, 2025, from 3:00 to 5:00 p.m. Eastern Standard Time. This virtual meeting will cover topics such as graft versus host disease, cord blood unit selection strategies, and potential new therapies under the C.W. Bill Young Cell Transplantation Program. The public can join and provide comments during the meeting, with written statements being accepted in advance. Registration details and additional information will be available on the Council's website.

    Simple Explanation

    The Advisory Council on Blood Stem Cell Transplantation is going to have an online meeting where they will talk about how doctors use special cells from blood for treating sickness. People can listen in and share their thoughts if they want to, but there are some details about who can speak and how that might be a bit confusing.

  • Type:Notice
    Citation:86 FR 11781
    Reading Time:about a minute or two

    The Advisory Council on Blood Stem Cell Transplantation (ACBSCT) has been rechartered by the Department of Health and Human Services (HHS), according to a notice published under the Federal Advisory Committee Act. The recharter, effective from February 19, 2021, allows the Council to operate until February 19, 2023. The ACBSCT provides expert advice and recommendations to HHS on blood stem cell transplantation programs and related policy matters. Further information, including the Council's charter, can be accessed on their official website or through the FACA database maintained by the General Services Administration.

    Simple Explanation

    The Advisory Council on Blood Stem Cell Transplantation helps give advice to make sure people who need special blood stem cells for treatment can get them, and they've gotten approval to keep meeting for another two years to continue their work.